A Bangladeshi pharma company will soon release a generic version of an expensive drug for cystic fibrosis that will allow hundreds of patients worldwide to access treatment.
The drug will cost around “$6,750 a year for adults, and around $2,000 per year for children.” This is compared to the current cost of treatment “priced between $300,000 and $370,000.”
You must log in or register to comment.
The only pharmaceutical option available for cystic fibrosis has for years been a combination treatment called ETI (elexacaftor/tezacaftor/ivacaftor) priced between $300,000 and $370,000.